COVID-19 Ag Respi-Strip

Manufactured by Coris BioConcept, Belgium - www.corisbio.com/ 

Related Scientific Literature

• Diagnostic techniques for COVID-19 and new developments
• Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis
• Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital
• Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies
• Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients
• Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs
• Clinically practiced and commercially viable nanobio engineered analytical methods for COVID-19 diagnosis
• Development and Potential Usefulness of the COVID-19 Ag Respi-Strip Diagnostic Assay in a Pandemic Context
• Assay Techniques and Test Development for COVID-19 Diagnosis.
• Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements